Elevated expression of NPAS2 in hepatocellular carcinoma (HCC) triggers CDC25A transactivation, dephosphorylates Bcl-2, and ultimately inhibits apoptosis [16]. Here, CDC25A is linked to hepatocellular carcinoma.